CC Grand Rounds: (1) Understanding and Ensuring the Quality of Cellular and Gene Therapies Through Science and Regulation (2) The Use of Molecular Assays to Assess the Potency of Cellular Therapies

Loading... Loading video...

Air date:	Wednesday, March 4, 2009, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 90 * This only includes stats from October 2011 and forward.
Category:	Clinical Center Grand Rounds
Runtime:	01:02:03
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	CC Grand Rounds Keith Wonnacott, PhD Chief, Cellular Therapies Branch Center for Biologics Evaluation and Research, FDA David Stroncek, MD Chief, Cell Processing Section Department of Transfusion Medicine, CC For more information, visit http://www.cc.nih.gov/about/news/grcurrent.html

NLM Title:	Understanding and ensuring the quality of cellular and gene therapies through science and regulation. The use of molecular assays to assess the potency of cellular therapies / Keith Wonnacott and David Stroncek.
Author:	Wonnacott, Keith. National Institutes of Health (U.S.)
Publisher:
Subjects:	Cell Transplantation Genetic Therapy Government Regulation Models, Molecular Quality Control
Publication Types:	Lecture Webcast
NLM Classification:	QU 300
NLM ID:	101501610
CIT Live ID:	7421
Permanent link:	https://videocast.nih.gov/watch=7421

NIH VideoCasting